Research - Rome, Lazio, Italy
Netabolics is specialized in developing solutions for the simulation and analysis of genome-scale metabolic networks. The company offers a cloud-computing platform for accelerating target selection in drug discovery using digital twins of human cells.Founded in June 2020, Netabolics is an AI-driven Biotech startup firm based in Rome (Italy). Our mission is to reduce clinical trial failures using predictive analytics of drug's biological targets.Netabolics can help you:- identifying biological targets responsible for the transition from healthy to diseased phenotypes.- estimate drug efficacy and toxicity on both healthy and diseased phenotypes for one or more biological targets. - estimate the best combination of biological targets to revert diseased towards healthy phenotypes.Our Unique Selling PropositionTECHNOLOGICAL INNOVATION - Our system is based on patent-pending methods and proprietary algorithms that have been developed over ten years of academic research.SUSTAINABLE AND EFFICIENT BUSINESS MODEL - Our subscription-based Software-as-a-Service platform allows scientists to have unlimited access to and full control over their analyses.SCALABILITY – Our simple, cost-effective, and scalable solution provides fast, reliable, and actionable insights to prioritize experimentation.
reCAPTCHA
Facebook Widget
Nginx
Google Tag Manager
Facebook Login (Connect)
Hotjar